SOURCE: DSM N.V.

October 06, 2006 02:23 ET

Repurchase of shares for balance sheet optimization plan

HEERLEN, NETHERLANDS -- (MARKET WIRE) -- October 6, 2006 --


Royal DSM N.V. has repurchased 915,041 of its own shares in the period from September 28 up to and including October 4, 2006 at an average price of EUR 34.72. This is in accordance with the share buyback program announced on September 27, 2006 that is designed to achieve the desired balance sheet structure. The consideration of this repurchase was EUR 31.8 million.

DSM

DSM is active worldwide in nutritional and pharma ingredients, performance materials and industrial chemicals. The company creates innovative products and services that help improve the quality of life. DSM's products are used in a wide range of end markets and applications such as human and animal nutrition and health, cosmetics, pharmaceuticals, automotive and transport, coatings, housing and electrics & electronics (E&E). DSM's strategy, named Vision 2010 - Building on Strengths (http://www.dsm.com/en_US/html/about/vision_2010.htm), focuses on accelerating profitable and innovative growth of the company's specialties portfolio. Market-driven growth, innovation and increased presence in emerging economies are key drivers of this strategy. The group has annual sales of over EUR 8 billion and employs some 22,000 people worldwide. DSM ranks among the global leaders in many of its fields. The company is headquartered in the Netherlands, with locations in Europe, Asia, Africa and the Americas. More information about DSM can be found at www.dsm.com.

For more information:

DSM Corporate Communications     DSM Investor Relations
Elvira Luykx                     Dries Ausems
tel. +31 (0) 45 5782035          tel. +31 (0) 45 5782864
fax  +31 (0) 45 5740680          fax  +31 (0) 45 5782595
e-mail media.relations@dsm.com   e-mail investor.relations@dsm.com

Copyright © Hugin ASA 2006. All rights reserved.

Contact Information